Needham initiated coverage of Waystar (WAY) with a Buy rating and $46 price target The firm believes the company is well positioned to gain share in the “highly complex and inefficient” revenue cycle management industry. Waystar offers “differentiated end-to-end RCM” platform to health systems trying to recover lost revenue, the analyst tells investors in a research note. Needham sees an attractive entry point at current share levelsl.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAY:
- Waystar price target raised to $49 from $47 at Citi
- Waystar’s Earnings Call: Growth and Innovation Shine
- Waystar price target raised to $52 from $49 at BofA
- Waystar Holding Corp. Receives Buy Rating Amid Strong Financial Performance and Strategic Advancements
- Waystar price target raised to $50 from $48 at Mizuho